ALPS Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

ALPS Advisors’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,696	Closed	-$365K	–	1162
2022 Q4	$365K	Buy	+29,696	New	+$708K	﹤0.01%	714

ALPS Advisors's CINC Position: Q1 2023 in Review

ALPS Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 29,696 shares — an estimated $365K sold.

ALPS Advisors first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $365K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

ALPS Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
ALPS Advisors sold 29,696 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $365K.
ALPS Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
ALPS Advisors's CinCor Pharma, Inc. Common Stock position peaked at $365K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on ALPS Advisors's 13F filing for Q1 2023, filed 10 May 2023.